Personal information

Countries

Bangladesh

Activities

Collapse all

Works (6)

Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants

mSphere
2024-03-26 | Journal article
DOI: 10.1128/msphere.00565-23
Contributors: Pinki Dash; Al Hakim; Aklima Akter; Hasan Al Banna; M. Hasanul Kaisar; Amena Aktar; Sultana Rownok Jahan; Jannatul Ferdous; Salima Raiyan Basher; Mohammad Kamruzzaman et al.
Source: check_circle
Crossref

Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh

mSphere
2023-10-24 | Journal article
DOI: 10.1128/msphere.00255-23
Contributors: M. Hasanul Kaisar; Meagan Kelly; Mohammad Kamruzzaman; Taufiqur R. Bhuiyan; Fahima Chowdhury; Ashraful Islam Khan; Regina C. LaRocque; Stephen B. Calderwood; Jason B. Harris; Richelle C. Charles et al.
Source: check_circle
Crossref

Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh.

Frontiers in immunology
2022-12-12 | Journal article
DOI: 10.3389/fimmu.2022.1052374
PMID: 36578502
PMC: PMC9791541
Contributors: Akhtar M; Basher SR; Nizam NN; Kamruzzaman M; Khaton F; Hasan Al Banna; Kaisar MH; Karmakar PC; Al Hakim; Akter A et al.
Source: Self-asserted source
M Hasanul Kaisar

Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh.

Frontiers in immunology
2022-09-28 | Journal article
DOI: 10.3389/fimmu.2022.929849
PMID: 36248882
PMC: PMC9554593
Contributors: Bhuiyan TR; Al Banna H; Kaisar MH; Karmakar PC; Al Hakim; Akter A; Ahmed T; Tauheed I; Islam S; Hasnat MA et al.
Source: Self-asserted source
M Hasanul Kaisar

Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.

mSphere
2021-07-07 | Journal article
DOI: 10.1128/msphere.00114-21
PMID: 34232076
PMC: PMC8386440
Contributors: Kamruzzaman M; Kelly M; Charles RC; Harris JB; Calderwood SB; Akter A; Biswas R; Kaisar MH; Md Taufiqur Rahman Bhuiyan; Ivers LC et al.
Source: Self-asserted source
M Hasanul Kaisar

Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.

mSphere
2021-04-28 | Journal article
DOI: 10.1128/msphere.01232-20
PMID: 33910997
PMC: PMC8092141
Contributors: Kaisar MH; Bhuiyan MS; Akter A; Saleem D; Iyer AS; Dash P; Al Hakim; Chowdhury F; Khan AI; Calderwood SB et al.
Source: Self-asserted source
M Hasanul Kaisar
How many people are using ORCID?